Barbara Jacobs

2.4k total citations
43 papers, 2.0k citations indexed

About

Barbara Jacobs is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Barbara Jacobs has authored 43 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 20 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Barbara Jacobs's work include Cytokine Signaling Pathways and Interactions (11 papers), interferon and immune responses (10 papers) and Immunotherapy and Immune Responses (8 papers). Barbara Jacobs is often cited by papers focused on Cytokine Signaling Pathways and Interactions (11 papers), interferon and immune responses (10 papers) and Immunotherapy and Immune Responses (8 papers). Barbara Jacobs collaborates with scholars based in United States, India and Austria. Barbara Jacobs's co-authors include Ernest C. Borden, Mamta Chawla‐Sarkar, Barbara P. Barna, Daniel J. Lindner, Songa Bae, Frederic J. Reu, Melinda L. Estes, Dong‐Er Zhang, Richard M. Ransohoff and Michael P. Malakhov and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Barbara Jacobs

42 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Jacobs United States 26 1.1k 951 611 238 172 43 2.0k
Ali A. Zarrin United States 20 1.3k 1.2× 1.1k 1.2× 404 0.7× 173 0.7× 198 1.2× 30 2.4k
Loretta Tuosto Italy 30 850 0.8× 1.7k 1.8× 447 0.7× 270 1.1× 193 1.1× 66 2.7k
S. Jaharul Haque United States 28 1.0k 1.0× 981 1.0× 980 1.6× 433 1.8× 184 1.1× 58 2.5k
Björn Rabe Germany 24 1.1k 1.1× 1.1k 1.2× 962 1.6× 280 1.2× 282 1.6× 32 2.6k
Glen M. Scholz Australia 23 806 0.8× 855 0.9× 248 0.4× 249 1.0× 144 0.8× 58 1.8k
Richard DeMarco United States 17 651 0.6× 561 0.6× 452 0.7× 158 0.7× 95 0.6× 26 1.5k
Barbara Molon Italy 22 664 0.6× 1.6k 1.7× 1.1k 1.7× 246 1.0× 123 0.7× 33 2.5k
Cristina Ulivieri Italy 23 649 0.6× 825 0.9× 295 0.5× 141 0.6× 141 0.8× 64 1.7k
Mikyoung Chang United States 21 1.2k 1.1× 1.6k 1.7× 514 0.8× 843 3.5× 198 1.2× 24 2.6k
Yuekang Xu China 25 629 0.6× 1.4k 1.5× 383 0.6× 150 0.6× 151 0.9× 53 2.3k

Countries citing papers authored by Barbara Jacobs

Since Specialization
Citations

This map shows the geographic impact of Barbara Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Jacobs more than expected).

Fields of papers citing papers by Barbara Jacobs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Jacobs. The network helps show where Barbara Jacobs may publish in the future.

Co-authorship network of co-authors of Barbara Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Jacobs. A scholar is included among the top collaborators of Barbara Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Jacobs. Barbara Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacobs, Barbara, et al.. (2023). Breaking the transactional mindset: A new path for healthcare leadership built on a commitment to human experience. SHILAP Revista de lepidopterología. 10(3). 6–12. 2 indexed citations
2.
Zhang, Kai, Philip C. Wong, Lei Zhang, et al.. (2012). A Notch1–neuregulin1 autocrine signaling loop contributes to melanoma growth. Oncogene. 31(43). 4609–4618. 52 indexed citations
3.
Borden, Ernest C., Barbara Jacobs, Lisa Rybicki, et al.. (2011). Gene Regulatory and Clinical Effects of Interferon β in Patients with Metastatic Melanoma: A Phase II Trial. Journal of Interferon & Cytokine Research. 31(5). 433–440. 25 indexed citations
4.
Olencki, Thomas, L. Wood, Lisa Rybicki, et al.. (2007). Gene Modulatory Effects, Pharmacokinetics, and Clinical Tolerance of Interferon-α1b: A Second Member of the Interferon-α Family. Clinical Pharmacology & Therapeutics. 81(3). 354–361. 14 indexed citations
5.
Bae, Songa, Venugopalan Cheriyath, Barbara Jacobs, Frederic J. Reu, & Ernest C. Borden. (2007). Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL. Oncogene. 27(4). 490–498. 58 indexed citations
6.
Cheriyath, Venugopalan, Barbara Jacobs, & Mohamad A. Hussein. (2007). Proteasome Inhibitors in the Clinical Setting. Drugs in R&D. 8(1). 1–12. 28 indexed citations
7.
Thakkar, Snehal G., David M. Peereboom, Thomas Olencki, et al.. (2006). Short Communication: Phase I Clinical and Gene Modulatory Evaluation of Tamoxifen and IFN- α 2b. Journal of Interferon & Cytokine Research. 26(11). 800–803. 2 indexed citations
8.
Markman, Maurie, Jerome L. Belinson, Kenneth Webster, et al.. (2004). Phase 2 Trial of Interferon-Beta as Second-Line Treatment of Ovarian Cancer, Fallopian Tube Cancer, or Primary Carcinoma of the Peritoneum. Oncology. 66(5). 343–346. 13 indexed citations
9.
Chawla‐Sarkar, Mamta, Songa Bae, Frederic J. Reu, et al.. (2004). Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death and Differentiation. 11(8). 915–923. 306 indexed citations
10.
Leaman, Douglas W., Mamta Chawla‐Sarkar, Barbara Jacobs, et al.. (2003). Novel Growth and Death Related Interferon-Stimulated Genes (ISGs) in Melanoma: Greater Potency of IFN- β Compared with IFN- α 2. Journal of Interferon & Cytokine Research. 23(12). 745–756. 105 indexed citations
11.
Bauer, Joseph A., et al.. (2003). IFN- α 2b and Thalidomide Synergistically Inhibit Tumor-Induced Angiogenesis. Journal of Interferon & Cytokine Research. 23(1). 3–10. 27 indexed citations
12.
Malakhov, Michael P., Keun Il Kim, Oxana A. Malakhova, et al.. (2003). High-throughput Immunoblotting. Journal of Biological Chemistry. 278(19). 16608–16613. 219 indexed citations
13.
Chawla‐Sarkar, Mamta, Douglas W. Leaman, Barbara Jacobs, et al.. (2002). Resistance to Interferons in Melanoma Cells Does Not Correlate with the Expression or Activation of Signal Transducer and Activator of Transcription 1 (Stat1). Journal of Interferon & Cytokine Research. 22(5). 603–613. 21 indexed citations
14.
Liu, Haiyan, Barbara Jacobs, Jinbo Liu, et al.. (2000). Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma. Cancer Immunology Immunotherapy. 49(6). 319–324. 63 indexed citations
15.
Liu, Jinbo, Melinda L. Estes, Judith Drazba, et al.. (2000). Anti-sense oligonucleotide of p21(waf1/cip1) prevents Interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells. Oncogene. 19(5). 661–669. 23 indexed citations
16.
Liu, Haiyan, Richard A. Prayson, Melinda L. Estes, et al.. (2000). IN VIVO EXPRESSION OF THE INTERLEUKIN 4 RECEPTOR ALPHA BY ASTROCYTES IN EPILEPSY CEREBRAL CORTEX. Cytokine. 12(11). 1656–1661. 33 indexed citations
17.
Barna, Barbara P., Gene H. Barnett, Barbara Jacobs, & Melinda L. Estes. (1993). Divergent responses of human astrocytoma and non-neoplastic astrocytes to tumor necrosis factor alpha involve the 55 kDa tumor necrosis factor receptor. Journal of Neuroimmunology. 43(1-2). 185–190. 19 indexed citations
18.
Barna, Barbara P., et al.. (1990). Human astrocytes proliferate in response to tumor necrosis factor alpha. Journal of Neuroimmunology. 30(2-3). 239–243. 113 indexed citations
19.
Estes, Melinda L., Richard M. Ransohoff, James T. McMahon, Barbara Jacobs, & Barbara P. Barna. (1990). Characterization of adult human astrocytes derived from explant culture. Journal of Neuroscience Research. 27(4). 697–705. 27 indexed citations
20.
Barna, Barbara P., S. M. Chou, Barbara Jacobs, Belinda Yen‐Lieberman, & Richard M. Ransohoff. (1989). Interferon-β impairs induction of HLA-DR antigen expression in cultured adult human astrocytes. Journal of Neuroimmunology. 23(1). 45–53. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ali A. Zarrin Breakdown of academic impact, for papers by Loretta Tuosto Breakdown of academic impact, for papers by S. Jaharul Haque Breakdown of academic impact, for papers by Björn Rabe Breakdown of academic impact, for papers by Glen M. Scholz Breakdown of academic impact, for papers by Richard DeMarco Breakdown of academic impact, for papers by Barbara Molon Breakdown of academic impact, for papers by Cristina Ulivieri Breakdown of academic impact, for papers by Mikyoung Chang Breakdown of academic impact, for papers by Yuekang Xu
Rankless by CCL
2026